HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-AUG-11 3TJD TITLE CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 837-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS JAK2, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.HUANG REVDAT 3 09-OCT-24 3TJD 1 REMARK SEQADV LINK REVDAT 2 28-DEC-11 3TJD 1 JRNL REVDAT 1 30-NOV-11 3TJD 0 JRNL AUTH L.B.SCHENKEL,X.HUANG,A.CHENG,H.L.DEAK,E.DOHERTY,R.EMKEY, JRNL AUTH 2 Y.GU,H.GUNAYDIN,J.L.KIM,J.LEE,R.LOBERG,P.OLIVIERI, JRNL AUTH 3 J.PISTILLO,J.TANG,Q.WAN,H.L.WANG,S.W.WANG,M.C.WELLS,B.WU, JRNL AUTH 4 V.YU,L.LIU,S.GEUNS-MEYER JRNL TITL DISCOVERY OF POTENT AND HIGHLY SELECTIVE THIENOPYRIDINE JRNL TITL 2 JANUS KINASE 2 INHIBITORS. JRNL REF J.MED.CHEM. V. 54 8440 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 22087750 JRNL DOI 10.1021/JM200911R REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 18691 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.286 REMARK 3 FREE R VALUE : 0.312 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4768 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3TJD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000067549. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19812 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.61000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5M OR 1.0 M LICL, 22.5-35% PEG6000, REMARK 280 PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.56000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.78000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 53.34000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 835 REMARK 465 SER A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ARG A 923 REMARK 465 GLY B 835 REMARK 465 SER B 836 REMARK 465 GLU B 837 REMARK 465 ASP B 838 REMARK 465 ARG B 839 REMARK 465 ALA B 920 REMARK 465 GLY B 921 REMARK 465 ARG B 922 REMARK 465 ARG B 923 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH PTR A 1007 O HOH A 13 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 847 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES REMARK 500 ARG A 980 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 860 31.80 -153.77 REMARK 500 ASP A 869 78.93 -108.29 REMARK 500 ASN A 874 64.93 32.31 REMARK 500 THR A 875 12.25 -145.73 REMARK 500 HIS A 886 86.19 -152.28 REMARK 500 ARG A 975 2.17 57.24 REMARK 500 ASP A 976 20.42 -145.90 REMARK 500 GLU A 987 -51.28 -26.57 REMARK 500 ASP A1068 40.92 -87.11 REMARK 500 GLN A1070 -132.89 -73.30 REMARK 500 TRP A1106 43.95 -95.13 REMARK 500 ALA A1131 -75.70 -70.36 REMARK 500 GLN B 872 26.77 48.43 REMARK 500 ARG B 975 -21.56 64.72 REMARK 500 ASN B 986 167.12 176.17 REMARK 500 GLU B 987 -19.73 -44.51 REMARK 500 ASP B1068 1.45 -69.25 REMARK 500 GLN B1070 -149.49 -76.44 REMARK 500 ASN B1084 35.31 -87.49 REMARK 500 TRP B1106 43.22 -97.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 847 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6TP A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6TP B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TJC RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8 DBREF 3TJD A 837 1132 UNP O60674 JAK2_HUMAN 837 1132 DBREF 3TJD B 837 1132 UNP O60674 JAK2_HUMAN 837 1132 SEQADV 3TJD GLY A 835 UNP O60674 EXPRESSION TAG SEQADV 3TJD SER A 836 UNP O60674 EXPRESSION TAG SEQADV 3TJD GLY B 835 UNP O60674 EXPRESSION TAG SEQADV 3TJD SER B 836 UNP O60674 EXPRESSION TAG SEQRES 1 A 298 GLY SER GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 A 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 A 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 A 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 A 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 A 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 A 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 A 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 A 298 ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE SEQRES 10 A 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 A 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 A 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 A 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 A 298 ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 A 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 A 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 A 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 A 298 LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU SEQRES 20 A 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 A 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 A 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 A 298 LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA GLY SEQRES 1 B 298 GLY SER GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 B 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 B 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 B 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 B 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 B 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 B 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 B 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 B 298 ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE SEQRES 10 B 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 B 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 B 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 B 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 B 298 ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 B 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 B 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 B 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 B 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 B 298 LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU SEQRES 20 B 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 B 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 B 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 B 298 LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA GLY MODRES 3TJD PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 3TJD PTR A 1008 TYR O-PHOSPHOTYROSINE MODRES 3TJD PTR B 1007 TYR O-PHOSPHOTYROSINE MODRES 3TJD PTR B 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET 6TP A 1 28 HET 6TP B 1 28 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 6TP 4-AMINO-2-[4-(TERT-BUTYLSULFAMOYL)PHENYL]-N- HETNAM 2 6TP METHYLTHIENO[3,2-C]PYRIDINE-7-CARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 6TP 2(C19 H22 N4 O3 S2) FORMUL 5 HOH *62(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 936 HIS A 944 1 9 HELIX 4 4 ASP A 949 THR A 969 1 21 HELIX 5 5 ALA A 978 ARG A 980 5 3 HELIX 6 6 PRO A 1017 TYR A 1021 5 5 HELIX 7 7 ALA A 1022 SER A 1029 1 8 HELIX 8 8 SER A 1032 THR A 1049 1 18 HELIX 9 9 GLU A 1052 LYS A 1055 5 4 HELIX 10 10 SER A 1056 GLY A 1066 1 11 HELIX 11 11 GLN A 1072 ASN A 1084 1 13 HELIX 12 12 PRO A 1095 TRP A 1106 1 12 HELIX 13 13 ASN A 1109 ARG A 1113 5 5 HELIX 14 14 SER A 1115 GLY A 1132 1 18 HELIX 15 15 GLU B 845 ARG B 847 5 3 HELIX 16 16 THR B 888 LEU B 905 1 18 HELIX 17 17 SER B 936 HIS B 944 1 9 HELIX 18 18 ASP B 949 LYS B 970 1 22 HELIX 19 19 ALA B 1022 SER B 1029 1 8 HELIX 20 20 SER B 1032 THR B 1049 1 18 HELIX 21 21 GLU B 1052 LYS B 1055 5 4 HELIX 22 22 SER B 1056 GLY B 1066 1 11 HELIX 23 23 MET B 1073 ASN B 1084 1 12 HELIX 24 24 PRO B 1095 TRP B 1106 1 12 HELIX 25 25 ASN B 1109 ARG B 1113 5 5 HELIX 26 26 SER B 1115 GLY B 1132 1 18 SHEET 1 A 5 LEU A 849 LYS A 857 0 SHEET 2 A 5 SER A 862 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 A 5 VAL A 878 LYS A 883 -1 O VAL A 879 N CYS A 866 SHEET 4 A 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 A 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1008 LYS A1009 0 SHEET 2 D 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 E 5 LEU B 849 LYS B 857 0 SHEET 2 E 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853 SHEET 3 E 5 GLU B 877 LEU B 884 -1 O VAL B 881 N GLU B 864 SHEET 4 E 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880 SHEET 5 E 5 TYR B 913 CYS B 917 -1 N LYS B 914 O ILE B 928 SHEET 1 F 2 TYR B 972 ILE B 973 0 SHEET 2 F 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 G 2 ILE B 982 ASN B 986 0 SHEET 2 G 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 H 2 PTR B1008 LYS B1009 0 SHEET 2 H 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.32 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 LINK C GLU B1006 N PTR B1007 1555 1555 1.33 LINK C PTR B1007 N PTR B1008 1555 1555 1.32 LINK C PTR B1008 N LYS B1009 1555 1555 1.33 SITE 1 AC1 13 HOH A 19 LEU A 855 LYS A 857 VAL A 863 SITE 2 AC1 13 ALA A 880 GLU A 930 TYR A 931 LEU A 932 SITE 3 AC1 13 GLY A 935 ARG A 980 ASN A 981 LEU A 983 SITE 4 AC1 13 ASP A 994 SITE 1 AC2 12 LEU B 855 GLY B 858 ALA B 880 LYS B 882 SITE 2 AC2 12 GLU B 930 TYR B 931 LEU B 932 PRO B 933 SITE 3 AC2 12 GLY B 935 ARG B 980 ASN B 981 LEU B 983 CRYST1 111.820 111.820 71.120 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008943 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008943 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014061 0.00000